fda drug safety communication semaglutide naion 2025 Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US as the first oral GLP‑1 receptor agonist for long‑term weight management and CV risk Can GLP-1 medications really Sem-O™ (Semaglutide):14mg third-party tested

fda drug safety communication semaglutide naion 2025 Novo Nordisk's Wegovy® pill (oral 25 mg, once daily) has just been approved by the US as the first oral GLP‑1 receptor agonist for long‑term weight management and CV risk Can GLP-1 medications really Sem-O™ (Semaglutide):14mg third-party tested

Can GLP-1 medications really lower your cancer risk? 🧐 Because obesity is linked to 13 types of cancer, researchers are seeing positive trends connecting weight-loss drugs to cancer prevention. James L. Wells

Dizziness: May cause sleepiness or light-headedness

third-party tested

Sem-O™ (Semaglutide):14mg

If you feel persistent abdominal pain, you must stop treatment and seek medical assistance